#	Pagina
attuale pagina	/open-h2020/projects/224648/index.html
-1	/open-h2020/projects/222146/index.html
-2	/open-h2020/projects/221538/index.html
-3	/open-h2020/projects/215103/index.html

Opendata, web and dolomites

BIOXPLOR SIGNED

BioXplor’s AI/Cognitive Software Platform accelerates and greatly reduces the cost of discovery research and clinical trials, with a primary focus on rare and inflammatory diseases data.

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

BIOXPLOR project word cloud

Explore the words cloud of the BIOXPLOR project. It provides you a very rough idea of what is the project "BIOXPLOR" about.

gained partnered score expansion bayer 2019 company environments rare institutes stratification customers genomes submissions antibodies reduces accelerates cognitive pharma biomarker pilots oncology inflammatory negotiating 2021 clinical 70 progress immunoassays orders skydeck acquiring forum merck savings successfully proteins primary biosimilars trials berkeley eur500k contracts pipeline time deploying acceleration biotech academic responder tests companies ai submission abcam data patient software multiyear bioxplor 2018 revenue revenues last seal tested super edemedx 13 uc 2m building drug shown indication platform 5x repositioning march 09 requested novartis discovery diseases eur750k excellence inflammation solution projected leads programs stage id 15 november space secondary recombinant 25x 100k tlr

Project "BIOXPLOR" data sheet

The following table provides information about the project.

Coordinator	BIOXPLOR LIMITED Organization address address: 9C THE BOTTLEWORKS city: Dublin postcode: Dublin 4 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Ireland [IE]
Project website	https://bioxplor.com/
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
Code Call	H2020-SMEInst-2018-2020-1
Funding Scheme	SME-1
Starting year	2019
Duration (year-month-day)	from 2019-07-01 to 2019-11-30

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	BIOXPLOR LIMITED BIOXPLOR LIMITED Organization address address: 9C THE BOTTLEWORKS city: Dublin postcode: Dublin 4 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	IE (Dublin)	coordinator	50˙000.00

Map

Project objective

BioXplor’s AI/Cognitive Software Platform accelerates and greatly reduces the cost of discovery research and clinical trials, with a primary focus on rare and inflammatory diseases data. The technology has shown a 5-25x reduction in time and 70% cost savings in pilots so far. (TLR stage 6 &7 tests in 5x Biotech and Pharma companies). BioXplor has achieved the Seal of Excellence for our Phase I application in March 2019 (score 13.5) and November 2018 (score 13.09) submissions. Last year, we have been completed acceleration programs at UC Berkeley’s SkyDeck and at Merck, and since then significant progress in building the platform to TLR stage 7 and acquiring new customers and revenue. The platform has been successfully used in tests with 5x Pharma and biotech companies (Merck, Bayer, Novartis, Abcam, EdemedX), and we have 5 new leads, for our platform for Discovery applications (antibodies, recombinant proteins, biomarker discovery, immunoassays, drug target ID) and Clinical applications (indication expansion, super-responder ID for drug-repositioning, and patient stratification for Biosimilars, all in inflammation projects with Biotech and Pharma). The current submission is aimed towards bringing BioXplor’s Platform to TLR stage 8, and deploying the our fully tested solution in operational environments at Pharma, Biotech and Academic Research Institutes, for which we are already negotiating pre-orders including 3 year multiyear contracts and 5-10 year partnerships. We have since partnered UC Berkeley, gained access to clinical trials patient data from a major pharma, become a discovery forum member with the 100K Genomes Project, and been selected as a consortium partner for an EU project in the oncology space. We have built a pipeline of EUR750k, with 2019 revenues projected at EUR500k and project revenues of $2M by 2021. We have been requested to deliver the solution to manage 15-20 clinical trials (secondary use of data) for a Top 2 Pharma company

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BIOXPLOR" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BIOXPLOR" are provided by the European Opendata Portal: CORDIS opendata.